Li Kong

447 total citations
16 papers, 353 citations indexed

About

Li Kong is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Li Kong has authored 16 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 4 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Li Kong's work include Pharmacogenetics and Drug Metabolism (4 papers), Pharmacological Effects of Natural Compounds (3 papers) and Catalytic C–H Functionalization Methods (2 papers). Li Kong is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Pharmacological Effects of Natural Compounds (3 papers) and Catalytic C–H Functionalization Methods (2 papers). Li Kong collaborates with scholars based in China, United States and Hong Kong. Li Kong's co-authors include Christopher H.K. Cheng, Ren Xiang Tan, Yongwei Zhang, Ren Xiang Tan, Andrew J. Walz, Larry K. Keefer, Joseph E. Saavedra, Wanbin Zhang, Harinath Chakrapani and Liang Wu and has published in prestigious journals such as NeuroImage, Cellular and Molecular Life Sciences and Journal of Ethnopharmacology.

In The Last Decade

Li Kong

15 papers receiving 337 citations

Peers

Li Kong
Li Kong
Citations per year, relative to Li Kong Li Kong (= 1×) peers Jianping Shen

Countries citing papers authored by Li Kong

Since Specialization
Citations

This map shows the geographic impact of Li Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Kong more than expected).

Fields of papers citing papers by Li Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Kong. The network helps show where Li Kong may publish in the future.

Co-authorship network of co-authors of Li Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Li Kong. A scholar is included among the top collaborators of Li Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Kong. Li Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Kong, Li, et al.. (2025). Criss-cross heart with complex cardiac malformation, situs inversus totalis and bronchial dysplasia. BMC Cardiovascular Disorders. 25(1). 248–248.
3.
Ji, Bing, et al.. (2024). Predicting the prognosis of patients with mild COVID-19 by chest CT based on machine learning. 7(2). 157–163. 1 indexed citations
5.
Kong, Li & Andrew J. Walz. (2021). Identification of human cytochrome P450 isozymes involved in the oxidative metabolism of carfentanil. Toxicology Letters. 343. 28–33. 5 indexed citations
7.
Wu, Liang, et al.. (2020). A Co(ii)-catalyzed asymmetric ring opening reaction of spiro-epoxyoxindoles with allylboron. Organic Chemistry Frontiers. 7(6). 862–867. 26 indexed citations
8.
Hsu, Fu‐Lian, Andrew J. Walz, Li Kong, et al.. (2019). Synthesis and μ-Opioid Activity of the Primary Metabolites of Carfentanil. ACS Medicinal Chemistry Letters. 10(11). 1568–1572. 16 indexed citations
10.
Ye, Chenghao, et al.. (2018). PdII‐Catalyzed Oxidative Tandem aza‐Wacker/Heck Cyclization for the Construction of Fused 5,6‐Bicyclic N,O‐Heterocycles. Chemistry - An Asian Journal. 13(15). 1897–1901. 11 indexed citations
11.
Chakrapani, Harinath, et al.. (2007). V-PROLI/NO, a Prodrug of the Nitric Oxide Donor, PROLI/NO. Organic Letters. 9(17). 3409–3412. 32 indexed citations
12.
Kong, Li, Joseph E. Saavedra, Gregory S. Buzard, et al.. (2005). Deamidation of peptides in aerobic nitric oxide solution by a nitrosative pathway. Nitric Oxide. 14(2). 144–151. 5 indexed citations
13.
Kong, Li, Christopher H.K. Cheng, & Ren Xiang Tan. (2004). Inhibition of MAO A and B by some plant-derived alkaloids, phenols and anthraquinones. Journal of Ethnopharmacology. 91(2-3). 351–355. 98 indexed citations
14.
Kong, Li, et al.. (2001). [Effects of processing on antioxidation of Radix et Rhizoma Rhei and Rhizoma Polygoni Cuspidati].. PubMed. 26(6). 388–91. 4 indexed citations
15.
Kong, Li, et al.. (2000). Inhibition of xanthine oxidase by liquiritigenin and isoliquiritigenin isolated from Sinofranchetia chinensis. Cellular and Molecular Life Sciences. 57(3). 500–505. 140 indexed citations
16.
Kong, Li, et al.. (1996). [Acute toxicity and anti-inflammatory effect of processed products of gamboge].. PubMed. 21(4). 214–6, 255. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026